| Title |
Co‐enzyme Q10 supplementation for the primary prevention of cardiovascular disease
|
|---|---|
| Published in |
Cochrane database of systematic reviews, December 2014
|
| DOI | 10.1002/14651858.cd010405.pub2 |
| Pubmed ID | |
| Authors |
Nadine Flowers, Louise Hartley, Daniel Todkill, Saverio Stranges, Karen Rees |
| Abstract |
Cardiovascular disease (CVD) remains the number one cause of death and disability worldwide and public health interventions focus on modifiable risk factors, such as diet. Coenzyme Q10 (CoQ10) is an antioxidant that is naturally synthesised by the body and can also be taken as a dietary supplement. Studies have shown that a CoQ10 deficiency is associated with cardiovascular disease. |
X Demographics
The data shown below were collected from the profiles of 32 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 3 | 9% |
| Saudi Arabia | 2 | 6% |
| Spain | 2 | 6% |
| United States | 2 | 6% |
| Canada | 1 | 3% |
| Unknown | 22 | 69% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 21 | 66% |
| Scientists | 4 | 13% |
| Practitioners (doctors, other healthcare professionals) | 4 | 13% |
| Science communicators (journalists, bloggers, editors) | 2 | 6% |
| Unknown | 1 | 3% |
Mendeley readers
The data shown below were compiled from readership statistics for 268 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | <1% |
| United States | 1 | <1% |
| Italy | 1 | <1% |
| Unknown | 265 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 42 | 16% |
| Student > Bachelor | 41 | 15% |
| Student > Ph. D. Student | 28 | 10% |
| Researcher | 27 | 10% |
| Other | 16 | 6% |
| Other | 35 | 13% |
| Unknown | 79 | 29% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 89 | 33% |
| Nursing and Health Professions | 29 | 11% |
| Agricultural and Biological Sciences | 13 | 5% |
| Biochemistry, Genetics and Molecular Biology | 10 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 8 | 3% |
| Other | 30 | 11% |
| Unknown | 89 | 33% |
Attention Score in Context
This research output has an Altmetric Attention Score of 37. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 August 2023.
All research outputs
#1,108,205
of 25,595,500 outputs
Outputs from Cochrane database of systematic reviews
#2,275
of 13,156 outputs
Outputs of similar age
#14,029
of 369,184 outputs
Outputs of similar age from Cochrane database of systematic reviews
#49
of 257 outputs
Altmetric has tracked 25,595,500 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,156 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.8. This one has done well, scoring higher than 82% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 369,184 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 257 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 81% of its contemporaries.